Thought leadership to move us forward

By Julia Yoon and Chris Borges Since OpenAI released ChatGPT to the public in November 2022, the use of and investment in generative artificial intelligence (AI) has exploded. Companies have released dozens of new models that can create text, images, sound, and even video, while investments in generative AI quintupled from

This transcript is from the 2024 LeadershIP Conference hosted at CSIS on April 9th, 2024. Watch the full video here. (DOWNLOAD) LeadershIP 2024 – Panel 4 Transcript Panel Description: National security priorities and technological leadership are inextricably linked. What can innovation, intellectual property, and competition policies do to help

This transcript is from the 2024 LeadershIP Conference hosted at CSIS on April 9th, 2024. Watch the full video here. (DOWNLOAD) LeadershIP 2024 – Panel 3 Transcript Panel Description: There are several legislative proposals on the table today affecting IP, antitrust, and competition. Is more (or less) needed to

This transcript is from the 2024 LeadershIP Conference hosted at CSIS on April 9th, 2024. Watch the full video here. (DOWNLOAD) LeadershIP 2024 – Panel 2 Transcript Panel Description: The Artificial Intelligence revolution has raised key questions that society has yet to answer, from pending litigation over training data

This transcript is from the 2024 LeadershIP Conference hosted at CSIS on April 9th, 2024. Watch the full video here. (DOWNLOAD) LeadershIP 2024 – Panel 1 Transcript Panel Description: The ongoing global IP policy developments are impacting U.S. technological and economic competitiveness. From March-In rights to Standards Essential

By Jeffery Depp and Tisyaketu Sirkar The journey of Katalin Kariko and Drew Weissman’s Nobel prize-winning invention of modified nucleotides—essential components of the mRNA vaccines—to their commercial application in vaccines that aided in arresting the Covid-19 pandemic illustrates the importance of a robust innovation system that is founded on secure intellectual

By Andrei Iancu and Rama Elluru This commentary from the CSIS-SCSP Task Force on IP in the AI Era was originally published in the Special Competitive Studies Project’s Substack on February 15, 2024. With roots in the U.S. constitution, patent rights provide an exclusive property right in new inventions like drugs,

By Kirti Gupta and Chris Borges On April 27, 2023, the European Commission published a draft proposal on standard essential patents (SEPs) seeking to address the perceived lack of transparency and predictability in the licensing of SEPs. The commission proposes the creation of a competence center within the European Union Intellectual

By Sujai Shivakumar and Thomas Howell   The Biden administration is considering exercising something called “march-in rights” as a policy prescription to curb drug prices. But as with any prescription, there is a need to weigh efficacy against the side-effects. In this case, there is evidence that the vast majority of